Medi First Plus Pms Relief Tablet, Coated
Product Images NDC 47682-723

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Medi First Plus Pms Relief (NDC 47682-723). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Unifirst First Aid Corporation, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

823r Mf Pms (823r Mf Pms Relief 82380 8 11 22 2)

823r Mf Pms (823r Mf Pms Relief 82380 8 11 22 2)
This appears to be the packaging information and drug facts for a medication called "MEDI-FIRST/Pain Reliever". It contains a combination of Acetaminophen, Pamabrom, and Pyrilamine maleate for relief of pain, diuretic effects, and histamine reactions typically associated with menstrual cycles. It is recommended to consult a doctor or pharmacist prior to taking the medication and to keep the product out of reach of children. The text is incomplete and contains errors, making it difficult to fully understand some sections.*
FDA Label Image

823rmfp Pms (823r Mfp Pms Relief 92380 8 11 22 1)

823rmfp Pms (823r Mfp Pms Relief 92380 8 11 22 1)
PMS Relief is a medication for relief from menstrual pain, water retention, and bloating. It contains acetaminophen 500 mg, diuretic with Pamabrom 25 mg, and antihistamine with Pyrilamine maleate 15 mg. The package is intended for households without young children. It also contains Drug Facts and Other information on how to use the medication. It contains inactive ingredients such as coscamieioss, coporon, DA Hue 12, and so on. If you have any questions, it is recommended to contact a physician or pharmacist.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.